# Cancer Demographics and Time-to-Care in Belize

Source: https://onco.cc/key-papers/paper-wong-cancer-time-to-care-belize-oncologist-2023/  
OnCo record `paper-wong-cancer-time-to-care-belize-oncologist-2023` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A review of the 465 people with cancer seen at Belize's public oncology clinic from 2018 to 2022 found that 68% arrived with stage 3 or 4 disease, and that a biopsy came a median of 130 days after the first symptoms.

## Summary

A retrospective chart review at the oncology clinic of the Karl Heusner Memorial Hospital, Belize City, set up in 2018 by the hospital, the Ministry of Health and the charity Global Oncology. The authors describe it as the first report of clinic-based cancer statistics for Belize, a country without a cancer registry, and measure the time from a patient's first symptoms to biopsy and treatment. The open full text adds that radiotherapy is not available in the country, that many patients who can afford to travel go to Mexico and Guatemala, and that the National Health Insurance scheme covers basic diagnostic services and primary care.

## Fields

- Kind: Key paper
- Last checked: 2026-11-16
- Journal: The Oncologist
- Year: 2023
- DOI: 10.1093/oncolo/oyad030
- Authors: Wong W, Dickerson JC, Valtis YK, et al.
- Findings: 465 patients with cancer presented to the clinic from 2018 to 2022; breast cancer (28%) and cervical cancer (12%) were the most common.; 68% presented with stage 3 or 4 disease, and 21% ever started treatment with curative intent.; Median time from patient-reported symptoms to a biopsy was 130 days, and to treatment 189 days; for breast cancer, 140 and 178 days.; At the clinic itself, biopsy and the start of chemotherapy each took under 30 days from the first visit.
- What it means: It gives Belize its first figures from its own patients, and shows that most of the delay comes before a person reaches the clinic.
- Caveats: One public clinic's patients, not national incidence; people treated privately or abroad are not counted.; Symptom onset was reported by patients, and no outcomes such as survival are reported.; The abstract and the full text give slightly different percentages for patients without insurance and without work (78% and 79%).

## Sources

- DOI: https://doi.org/10.1093/oncolo/oyad030
- PubMed: https://pubmed.ncbi.nlm.nih.gov/36928719/

## Connected records

- key papers: [Assessment of Cervical Cancer Prevention and Treatment Infrastructure in Belize](https://onco.cc/key-papers/paper-neibart-cervical-infrastructure-belize-jcogo-2021/), [Barriers and facilitators to effective cervical cancer screening in Belize: a qualitative analysis](https://onco.cc/key-papers/paper-mittal-cervical-screening-barriers-belize-ccc-2023/)
- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/), [Cervical cancer](https://onco.cc/cancers/cervical/)
- institutions: [Belize Cancer Society](https://onco.cc/institutions/belize-cancer-society/), [Karl Heusner Memorial Hospital](https://onco.cc/institutions/khmh-belize/), [Ministry of Health and Wellness, Belize](https://onco.cc/institutions/moh-belize/), [National Health Insurance, Belize](https://onco.cc/institutions/nhi-belize/)

---
JSON: https://onco.cc/api/v1/entities/paper-wong-cancer-time-to-care-belize-oncologist-2023.json